Definium Therapeutics Income Statement (2021-2026) | DFTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Shares Outstanding (Entity) (Quarter)																				0.11B
Operating items
Research & Development (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.02B	0.03B	0.03B	0.03B	0.04B	0.05B
Selling, General & Administrative (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.03B
Operating Expenses (Quarter)																				0.08B
Other Operating Expenses (Quarter)														-0.00B				-0.00B
Operating Income (Quarter)																				-0.08B
EBIT (Quarter)																				-0.08B
Non-operating items
Non Operating Investment Income (Quarter)																				-0.00B
Interest & Investment Income (Quarter)																				0.00B
Other Non Operating Income (Quarter)																				-0.08B
Net income details
EBT (Quarter)																				-0.31B
Tax Provisions (Quarter)		-0.02B				0.00B
Profit After Tax (Quarter)																				-0.16B
Income from Continuing Operations (Quarter)																				-0.31B
Consolidated Net Income (Quarter)																				-0.31B
Income towards Parent Company (Quarter)																				-0.31B
Net Income towards Common Stockholders (Quarter)																				-0.16B
Additional items
EPS (Basic) (Quarter)																				-1.44
EPS (Diluted) (Quarter)																				-1.44
Shares Outstanding (Quarter)																				0.11B
Shares Outstanding (Diluted) (Quarter)																				0.11B
EBITDA (Quarter)																				-0.08B
Interest Expenses (Quarter)																				0.23B
Tax Rate (Quarter)		-74.40				-4.57